Ozempic Dosing and Administration Guidelines for Type 2 Diabetes

Standard Dosing Protocol and Administration

The American College of Cardiology recommends administering Ozempic once weekly on the same day each week, which can be given at any time of day, with or without meals 1

No dose adjustments are required for patients with renal impairment, including end-stage renal disease, or hepatic impairment, as stated by the guideline society 2
The FDA warns of a risk of thyroid C-cell tumors observed in rodents, with human relevance undetermined, and contraindicates Ozempic in patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 2
Key safety concerns include gastrointestinal disorders, such as nausea, vomiting, diarrhea, and constipation, which can be minimized with a gradual titration schedule, as well as cholelithiasis and gallstone-related complications, severe constipation, elevated heart rate, and hypoglycemia risk when combined with insulin or insulin secretagogues 1, 2

For patients with established cardiovascular disease, the American Heart Association prefers GLP-1 receptor agonists, including semaglutide, as first-line therapy with or without metformin, due to their proven cardiovascular benefits 3